Justice Department, Drug Enforcement Administration Briefing 2026-05-04 Estimated reading time: 5 minutes 1. Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance Link: https://www.federalregister.gov/documents/2026/05/04/2026-08595/specific-listing-for-hexahydrocannabinol-a-currently-controlled-schedule-i-substance Sub: Justice Department, Drug Enforcement Administration Content: The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H- benzo[c]chromen-1-ol (also known as hexahydrocannabinol, and HHC) in schedule I of the Controlled Substances Act (CSA). Although hexahydrocannabinol is not specifically listed in schedule I of the CSA with its own unique drug code, it is a schedule I controlled substances in the United States under drug code 7370 because it meets the definition of tetrahydrocannabinols, a schedule I hallucinogen. Therefore, DEA is simply amending the schedule I hallucinogenic substances list to separately include hexahydrocannabinol. 2. Bulk Manufacturer of Controlled Substances Application: Patheon API Inc. Link: https://www.federalregister.gov/documents/2026/05/04/2026-08588/bulk-manufacturer-of-controlled-substances-application-patheon-api-inc Sub: Justice Department, Drug Enforcement Administration Content: Patheon API Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 3. Importer of Controlled Substances Application: ANI Pharmaceuticals Inc. Link: https://www.federalregister.gov/documents/2026/05/04/2026-08587/importer-of-controlled-substances-application-ani-pharmaceuticals-inc Sub: Justice Department, Drug Enforcement Administration Content: ANI Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 4. Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc. Link: https://www.federalregister.gov/documents/2026/05/04/2026-08586/bulk-manufacturer-of-controlled-substances-application-ani-pharmaceuticals-inc Sub: Justice Department, Drug Enforcement Administration Content: ANI Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 5. Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc. Link: https://www.federalregister.gov/documents/2026/05/04/2026-08585/bulk-manufacturer-of-controlled-substances-application-patheon-pharmaceuticals-inc Sub: Justice Department, Drug Enforcement Administration Content: Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 6. Notice of Lodging of Proposed Consent Decree Under the Resource Conservation and Recovery Act Link: https://www.federalregister.gov/documents/2026/05/04/2026-08581/notice-of-lodging-of-proposed-consent-decree-under-the-resource-conservation-and-recovery-act Sub: Justice Department Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-04-30
Justice Department Briefing 2026-04-30 Estimated reading time: 5 minutes 1. Office of the Chief Administrative Hearing Officer, Chief Administrative Law Judge Link: https://www.federalregister.gov/documents/2026/04/30/2026-08484/office-of-the-chief-administrative-hearing-officer-chief-administrative-law-judge Sub: Justice Department Content: On October 7, 2020, the Department of Justice ("Department") published an interim final rule ("IFR") amending the regulations governing the Office of the Chief Administrative Hearing Officer ("OCAHO"). The amendments reflected changes related to the creation of the position of the Chief Administrative Law Judge ("CALJ") and made additional related technical changes. This final rule adopts the provisions of the IFR with minor technical corrections. 2. Notice of Lodging of Proposed Second Modification To Consent Decree Under the Comprehensive Environmental Response Compensation and Liability Act Link: https://www.federalregister.gov/documents/2026/04/30/2026-08404/notice-of-lodging-of-proposed-second-modification-to-consent-decree-under-the-comprehensive Sub: Justice Department Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-04-29
Justice Department Briefing 2026-04-29 Estimated reading time: 5 minutes 1. Notice of Requests for Certification of Capital Counsel Mechanisms of Florida and Mississippi Link: https://www.federalregister.gov/documents/2026/04/29/2026-08319/notice-of-requests-for-certification-of-capital-counsel-mechanisms-of-florida-and-mississippi Sub: Justice Department Content: This notice advises the public that the States of Florida and Mississippi have requested certification of their capital counsel mechanisms by the Attorney General and that public comments may be submitted to the Department of Justice regarding these requests. 2. Privacy Act of 1974; System of Records Link: https://www.federalregister.gov/documents/2026/04/29/2026-08318/privacy-act-of-1974-system-of-records Sub: Justice Department Content: Pursuant to the Privacy Act of 1974, and Office of Management and Budget (OMB) Circular No. A-108, notice is hereby given that the United States Department of Justice (Department or DOJ) Drug Enforcement Administration (DEA) proposes to develop a new system of records titled “DEA Inventory Tracking Records,” which will serve as the repository of inventory management records at certain warehouse and depot locations. JUSTICE/DEA-023 combines user information from various data sources to provide an authoritative record at central warehouse locations to manage equipment distribution and lifecycle administration for different types of equipment. 3. Privacy Act of 1974; Systems of Records Link: https://www.federalregister.gov/documents/2026/04/29/2026-08317/privacy-act-of-1974-systems-of-records Sub: Justice Department Content: Pursuant to the Privacy Act of 1974 (5 U.S.C. 552a), CRT proposes to establish a new system of records titled “Civil Rights Division Reporting Portal,” JUSTICE/CRT-012. This system of records modernizes how the Division receives reports of alleged civil rights violations from the public. It operates as a web application and database where the public will be able to access a streamlined, responsive web form to report potential violations of federal civil rights laws and securely submit the completed form to the database. The system also allows CRT to add reports received through non-web channels, such as hardcopy mail, telephone, email, or fax to the portal’s database. This system enables the Division to more efficiently review and process reports to determine whether a report may contain information that supports further inquiry by CRT or pertains to ongoing investigations and legal proceedings on various issues related to protecting civil rights. This system will also allow the Division to provide status updates to the public, track portal metrics, and analyze progress on the concerns raised by the reports. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
Marijuana Rescheduling: FDA-Approved Products Moved to Schedule III Estimated reading time: 3 minutes In a significant change, the Drug Enforcement Administration (DEA) has issued a new rule to reschedule certain marijuana-based products. This change moves marijuana in FDA-approved products and those under state medical licenses from Schedule I to Schedule III. The rule is effective as of April 28, 2026. This change means these specified products are now recognized for medical value, aligning with international obligations. Previously, under the Controlled Substances Act, marijuana was in Schedule I. This classification is for substances with a high potential for abuse and no accepted medical use. Schedule III, however, includes drugs with a moderate to low potential for physical and psychological dependence. The DEA’s decision follows a recommendation from the Department of Health and Human Services. This decision recognizes marijuana’s lower risk of abuse compared to other Schedule I and II drugs. This update comes after thorough evaluations. The evaluations considered the frequency of marijuana use and its societal impact. Despite its high usage, marijuana shows fewer severe negative outcomes than some Schedule I and II drugs. A critical part of the rule is ensuring these products meet U.S. treaty obligations. Import and export of marijuana products still require permits. This maintains the U.S.’s commitment to the Single Convention on Narcotic Drugs. State medical marijuana licensees will benefit from this rule. They will no longer face certain federal tax penalties, such as the deduction disallowance under Section 280E of the Internal Revenue Code. The rule also includes an expedited registration process. This process is for entities with state medical marijuana licenses, making it easier to engage in activities like distribution. This regulatory change provides clarity and aligns U.S. law with current medicinal uses of marijuana. It marks a crucial development in the ongoing dialogue around marijuana’s legal status in the United States. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-04-28
Justice Department Briefings — April 28, 2026 Estimated reading time: 5 minutes 1. Meeting of the CJIS Advisory Policy Board Link: https://www.federalregister.gov/documents/2026/04/28/2026-08197/meeting-of-the-cjis-advisory-policy-board Sub: Justice Department, Federal Bureau of Investigation Content: The purpose of this notice is to announce a meeting of the Federal Bureau of Investigation's (FBI) Criminal Justice Information Services (CJIS) Advisory Policy Board (APB). The CJIS APB is a federal advisory committee established pursuant to the Federal Advisory Committee Act (FACA). This meeting announcement is being published as required by Section 10 of the FACA. 2. Schedules of Controlled Substances: Rescheduling of Marijuana; Withdrawal Link: https://www.federalregister.gov/documents/2026/04/28/2026-08178/schedules-of-controlled-substances-rescheduling-of-marijuana-withdrawal Sub: Justice Department, Drug Enforcement Administration Content: The Department of Justice published a notice of proposed rulemaking in the Federal Register on May 21, 2024, which proposed to transfer marijuana from schedule I of the Controlled Substances Act to schedule III. The Drug Enforcement Administration ("DEA") published a notice of hearing on the proposed rule in the Federal Register on August 29, 2024. Upon further review, DEA is withdrawing the notice of hearing and terminating the pending hearing proceedings. As directed by Executive Order 14370, DEA has determined that the most expeditious manner of completing the rulemaking process in accordance with Federal law is to terminate the pending hearing proceedings and initiate new hearing proceedings. DEA is publishing a new notice of hearing elsewhere in this issue of the Federal Register. 3. Schedules of Controlled Substances: Rescheduling of Marijuana Link: https://www.federalregister.gov/documents/2026/04/28/2026-08177/schedules-of-controlled-substances-rescheduling-of-marijuana Sub: Justice Department, Drug Enforcement Administration Content: This is notice that the Drug Enforcement Administration ("DEA") will hold a hearing with respect to the proposed rescheduling of marijuana into schedule III of the Controlled Substances Act beginning June 29, 2026. The proposed rescheduling of marijuana was initially proposed in a Notice of Proposed Rulemaking published in the Federal Register on May 21, 2024. In accordance with Executive Order 14370, DEA is completing this process in the most expeditious manner in accordance with Federal law. 4. Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements Link: https://www.federalregister.gov/documents/2026/04/28/2026-08176/schedules-of-controlled-substances-rescheduling-of-food-and-drug-administration-approved-products Sub: Justice Department, Drug Enforcement Administration Content: With the issuance of this final rule, which constitutes a final order, the Acting Attorney General of the U.S. Department of Justice places drug products containing marijuana that have been approved by the Food and Drug Administration (FDA) in schedule III of the Controlled Substances Act ("CSA"). This action is required to satisfy the responsibility of the Administrator under the CSA to place a drug in the schedule he deems most appropriate to carry out United States obligations under the Single Convention on Narcotic Drugs, 1961. In general, this final rule applies to marijuana as defined in the CSA, marijuana extracts, and delta-9-tetrahydrocannabinol and other compounds derived from the marijuana plant (other than the mature stalks and seeds) that falls outside the definition of hemp, to the extent that any of these are included in an FDA-approved drug product or are subject to a state-issued license to manufacture, distribute, and/or dispense marijuana or products containing marijuana for medical purposes ("state medical marijuana license"). Also consistent therewith, this final rule adds such drugs to the list of substances that may only be imported or exported pursuant to a permit. This final rule also establishes an expedited registration process under 21 CFR part 1301 for entities holding state medical marijuana licenses, enabling such entities to engage in the manufacture, distribution, and/or dispensing of marijuana for medical purposes under federal law consistent with the requirements of the Single Convention. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Antitrust Division Briefing 2026-04-24
Justice Department Briefing 2026-04-24 Estimated reading time: 5 minutes 1. Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I Link: https://www.federalregister.gov/documents/2026/04/24/2026-08104/schedules-of-controlled-substances-placement-of-mdmb-4en-pinaca-in-schedule-i Sub: Justice Department, Drug Enforcement Administration Content: With the issuance of this final rule, the Drug Enforcement Administration places methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H- indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle MDMB-4en-PINACA. 2. United States et al. v. Constellation Energy Corporation, Inc. et al. Response of Plaintiff United States to Public Comments on the Proposed Final Judgment Link: https://www.federalregister.gov/documents/2026/04/24/2026-08095/united-states-et-al-v-constellation-energy-corporation-inc-et-al-response-of-plaintiff-united-states Sub: Justice Department, Antitrust Division Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Antitrust Division Briefing 2026-04-23
Justice Department, Antitrust Division Briefing 2026-04-23 Estimated reading time: 5 minutes 1. Notice Pursuant to the Defense Production Act of 1950 Link: https://www.federalregister.gov/documents/2026/04/23/2026-07900/notice-pursuant-to-the-defense-production-act-of-1950 Sub: Justice Department, Antitrust Division Content: Notice is hereby given pursuant to section 708 of the Defense Production Act of 1950 ("DPA"), that the Acting Assistant Attorney General finds, with respect to the Implementing Voluntary Agreements Under the Defense Production Act ("Voluntary Agreement") proposed by the Department of Energy ("DOE"), that the purposes of section 708(c)(1) of the DPA may not reasonably be achieved through plans of action having less anticompetitive effects or without any plans of action. Given this finding, the proposed Plans of Action may become effective following the publication of this notice. 2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement of a Previously Approved Collection; Title: National Motor Vehicle Title Information System (NMVTIS) Link: https://www.federalregister.gov/documents/2026/04/23/2026-07895/agency-information-collection-activities-proposed-ecollection-ecomments-requested-reinstatement-of-a Sub: Justice Department Content: The Office of Justice Programs, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement of a Previously Approved Collection; Title: Patrick Leahy Bulletproof Vest Partnership Program Link: https://www.federalregister.gov/documents/2026/04/23/2026-07893/agency-information-collection-activities-proposed-ecollection-ecomments-requested-reinstatement-of-a Sub: Justice Department Content: The Office of Justice Programs, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 4. Notice Pursuant to the Defense Production Act of 1950 Link: https://www.federalregister.gov/documents/2026/04/23/2026-07892/notice-pursuant-to-the-defense-production-act-of-1950 Sub: Justice Department, Antitrust Division Content: Notice is hereby given pursuant to section 708 of the Defense Production Act of 1950 ("DPA"), that the Acting Assistant Attorney General finds, with respect to the Implementing Voluntary Agreements Under the Defense Production Act ("Voluntary Agreement") proposed by the Department of Energy ("DOE"), that the purposes of section 708(c)(1) of the DPA may not reasonably be achieved through a voluntary agreement having less anticompetitive effects or without any voluntary agreement. Given this finding, the proposed revised Voluntary Agreement may become effective following the publication of this notice. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-04-21
Justice Department, Drug Enforcement Administration Briefing 2026-04-21 Estimated reading time: 5 minutes 1. Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences Link: https://www.federalregister.gov/documents/2026/04/21/2026-07698/bulk-manufacturer-of-controlled-substances-application-ajna-biosciences Sub: Justice Department, Drug Enforcement Administration Content: AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 2. Importer of Controlled Substances Application: VA Cooperative Studies Program Link: https://www.federalregister.gov/documents/2026/04/21/2026-07697/importer-of-controlled-substances-application-va-cooperative-studies-program Sub: Justice Department, Drug Enforcement Administration Content: VA Cooperative Studies Program has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 3. Importer of Controlled Substances Application: Leading Pharma LLC Link: https://www.federalregister.gov/documents/2026/04/21/2026-07696/importer-of-controlled-substances-application-leading-pharma-llc Sub: Justice Department, Drug Enforcement Administration Content: Leading Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Antitrust Division Briefing 2026-04-20
Justice Department Briefing 2026-04-20 Estimated reading time: 5 minutes 1. Extension of Compliance Dates for Nondiscrimination on the Basis of Disability; Accessibility of Web Information and Services of State and Local Government Entities Link: https://www.federalregister.gov/documents/2026/04/20/2026-07663/extension-of-compliance-dates-for-nondiscrimination-on-the-basis-of-disability-accessibility-of-web Sub: Justice Department Content: By this Interim Final Rule ("IFR"), the Department of Justice ("Department") is revising the regulations implementing title II of the Americans with Disabilities Act ("ADA") to extend the compliance dates for the requirements for web content and mobile application ("app") accessibility that were adopted on April 24, 2024. The compliance date for State and local government entities with a total population of 50,000 or more is extended from April 24, 2026, to April 26, 2027. The compliance date for public entities with a total population of less than 50,000, or any special district government, is extended from April 26, 2027, to April 26, 2028. 2. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Blockchain Security Standards Council, Inc. Link: https://www.federalregister.gov/documents/2026/04/20/2026-07658/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-blockchain-security Sub: Justice Department, Antitrust Division Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-04-17
Justice Department Briefing 2026-04-17 Estimated reading time: 5 minutes 1. Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval has Expired: Census of State and Local Law Enforcement Agencies (CSLLEA) Link: https://www.federalregister.gov/documents/2026/04/17/2026-07567/agency-information-collection-activities-proposed-ecollection-ecomments-requested-reinstatement-with Sub: Justice Department Content: The Bureau of Justice Statistics, Department of Justice (DOJ) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc. Link: https://www.federalregister.gov/documents/2026/04/17/2026-07562/bulk-manufacturer-of-controlled-substances-application-usona-institute-inc Sub: Justice Department, Drug Enforcement Administration Content: Usona Institute, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 3. Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals Link: https://www.federalregister.gov/documents/2026/04/17/2026-07561/importer-of-controlled-substances-application-royal-emerald-pharmaceuticals Sub: Justice Department, Drug Enforcement Administration Content: Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 4. Importer of Controlled Substances Application: Quagen Pharmaceuticals LLC Link: https://www.federalregister.gov/documents/2026/04/17/2026-07559/importer-of-controlled-substances-application-quagen-pharmaceuticals-llc Sub: Justice Department, Drug Enforcement Administration Content: Quagen Pharmaceuticals LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 5. Importer of Controlled Substances Application: LTS Therapy Systems, LLC Link: https://www.federalregister.gov/documents/2026/04/17/2026-07558/importer-of-controlled-substances-application-lts-therapy-systems-llc Sub: Justice Department, Drug Enforcement Administration Content: LTS Therapy Systems, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 6. Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Drug Use Statement Link: https://www.federalregister.gov/documents/2026/04/17/2026-07520/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Drug Enforcement Administration, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-04-15
Justice Department Briefing 2026-04-15 Estimated reading time: 5 minutes 1. Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; U.S. Department of Justice Self Reportable Activities Link: https://www.federalregister.gov/documents/2026/04/15/2026-07330/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Justice Management Division, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of Currently Approved Collection Link: https://www.federalregister.gov/documents/2026/04/15/2026-07287/agency-information-collection-activities-proposed-ecollection-ecomments-requested-extension-of Sub: Justice Department Content: The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-04-10
Justice Department Briefing 2026-04-10 Estimated reading time: 5 minutes 1. Amendment to Registration Statement of Foreign Agents (Form NSD-5) Link: https://www.federalregister.gov/documents/2026/04/10/2026-07023/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Foreign Agents Registration Act (FARA) Unit, Counterintelligence and Export Control Section (CES), National Security Division (NSD), U.S. Department of Justice, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Exhibit A to Registration Statement of Foreign Agents (Form NSD-3) Link: https://www.federalregister.gov/documents/2026/04/10/2026-07022/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Foreign Agents Registration Act (FARA) Unit, Counterintelligence and Export Control Section (CES), National Security Division (NSD), U.S. Department of Justice, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Supplemental Statement to Registration Statement of Foreign Agents (Form NSD-2) Link: https://www.federalregister.gov/documents/2026/04/10/2026-07021/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Foreign Agents Registration Act (FARA) Unit, Counterintelligence and Export Control Section (CES), National Security Division (NSD), U.S. Department of Justice, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 4. Short Form to Registration Statement of Foreign Agents (Form NSD-6) Link: https://www.federalregister.gov/documents/2026/04/10/2026-07020/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Foreign Agents Registration Act (FARA) Unit, Counterintelligence and Export Control Section (CES), National Security Division (NSD), U.S. Department of Justice, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 5. Registration Statement of Foreign Agents (Form NSD-1) Link: https://www.federalregister.gov/documents/2026/04/10/2026-07019/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Foreign Agents Registration Act (FARA) Unit, Counterintelligence and Export Control Section (CES), National Security Division (NSD), U.S. Department of Justice, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 6. Exhibit B to Registration Statement of Foreign Agents (Form NSD-4) Link: https://www.federalregister.gov/documents/2026/04/10/2026-07018/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Foreign Agents Registration Act (FARA) Unit, Counterintelligence and Export Control Section (CES), National Security Division (NSD), U.S. Department of Justice, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 7. Notice of Lodging of Proposed Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act Link: https://www.federalregister.gov/documents/2026/04/10/2026-06975/notice-of-lodging-of-proposed-consent-decree-under-the-comprehensive-environmental-response Sub: Justice Department Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-04-03
Justice Department, Drug Enforcement Administration Briefing 2026-04-03 Estimated reading time: 5 minutes 1. Bulk Manufacturer of Controlled Substances Application: Purisys, LLC Link: https://www.federalregister.gov/documents/2026/04/03/2026-06524/bulk-manufacturer-of-controlled-substances-application-purisys-llc Sub: Justice Department, Drug Enforcement Administration Content: Purisys, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 2. Designation of P2P Methyl Glycidic Acid as a List I Chemical Link: https://www.federalregister.gov/documents/2026/04/03/2026-06523/designation-of-p2p-methyl-glycidic-acid-as-a-list-i-chemical Sub: Justice Department, Drug Enforcement Administration Content: The Drug Enforcement Administration is finalizing the control of 2-methyl-3-phenyloxirane-2-carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible, as a list I chemical under the Controlled Substances Act (CSA). P2P methyl glycidic acid is used in the illicit manufacture of the controlled substances phenylacetone (also known as phenyl-2-propanone or P2P), methamphetamine, and amphetamine, and it is important to the manufacture of these substances. This final rule subjects handlers of P2P methyl glycidic acid to the chemical regulatory provisions of the CSA and its implementing regulations. 3. Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute Link: https://www.federalregister.gov/documents/2026/04/03/2026-06522/bulk-manufacturer-of-controlled-substances-application-research-triangle-institute Sub: Justice Department, Drug Enforcement Administration Content: Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 4. Importer of Controlled Substances Application: Lipomed/LGC Standards Link: https://www.federalregister.gov/documents/2026/04/03/2026-06521/importer-of-controlled-substances-application-lipomedlgc-standards Sub: Justice Department, Drug Enforcement Administration Content: Lipomed/LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 5. Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC Link: https://www.federalregister.gov/documents/2026/04/03/2026-06520/importer-of-controlled-substances-application-blue-rabbit-veterinary-llc Sub: Justice Department, Drug Enforcement Administration Content: Blue Rabbit Veterinary LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-04-01
Justice Department, Drug Enforcement Administration Briefing — April 1, 2026 Estimated reading time: 5 minutes 1. Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017 Link: https://www.federalregister.gov/documents/2026/04/01/C1-2026-02288/registering-emergency-medical-services-agencies-under-the-protecting-patient-access-to-emergency Sub: Justice Department, Drug Enforcement Administration 2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Title-Voice of Customer Survey Link: https://www.federalregister.gov/documents/2026/04/01/2026-06312/agency-information-collection-activities-proposed-ecollection-ecomments-requested-title-voice-of Sub: Justice Department Content: The Federal Bureau of Investigation, Office of Private Sector, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Importer of Controlled Substances Application: Research Triangle Institute Link: https://www.federalregister.gov/documents/2026/04/01/2026-06311/importer-of-controlled-substances-application-research-triangle-institute Sub: Justice Department, Drug Enforcement Administration Content: Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 4. Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC Link: https://www.federalregister.gov/documents/2026/04/01/2026-06261/bulk-manufacturer-of-controlled-substances-application-pharmaron-manufacturing-services-us-llc Sub: Justice Department, Drug Enforcement Administration Content: Pharmaron Manufacturing Services (US) LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 5. Importer of Controlled Substances Application: Sterling Wisconsin, LLC Link: https://www.federalregister.gov/documents/2026/04/01/2026-06260/importer-of-controlled-substances-application-sterling-wisconsin-llc Sub: Justice Department, Drug Enforcement Administration Content: Sterling Wisconsin, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 6. Importer of Controlled Substances Application: Indivior Manufacturing LLC Link: https://www.federalregister.gov/documents/2026/04/01/2026-06259/importer-of-controlled-substances-application-indivior-manufacturing-llc Sub: Justice Department, Drug Enforcement Administration Content: Indivior Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 7. Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (Document 2026-06258) Link: https://www.federalregister.gov/documents/2026/04/01/2026-06258/importer-of-controlled-substances-application-fisher-clinical-services-inc Sub: Justice Department, Drug Enforcement Administration Content: Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 8. Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (Document 2026-06257) Link: https://www.federalregister.gov/documents/2026/04/01/2026-06257/importer-of-controlled-substances-application-fisher-clinical-services-inc Sub: Justice Department, Drug Enforcement Administration Content: Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 9. Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals Link: https://www.federalregister.gov/documents/2026/04/01/2026-06256/bulk-manufacturer-of-controlled-substances-application-royal-emerald-pharmaceuticals Sub: Justice Department, Drug Enforcement Administration Content: Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-03-30
Justice Department Briefing 2026-03-30 Estimated reading time: 5 minutes 1. Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: Census of Prosecutor Offices Link: https://www.federalregister.gov/documents/2026/03/30/2026-06118/agency-information-collection-activities-proposed-ecollection-ecomments-requested-reinstatement-with Sub: Justice Department Content: The Department of Justice (DOJ), Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Importer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC Link: https://www.federalregister.gov/documents/2026/03/30/2026-06053/importer-of-controlled-substances-application-pharmaron-manufacturing-services-us-llc Sub: Justice Department, Drug Enforcement Administration Content: Pharmaron Manufacturing Services (US) LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 3. Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC Link: https://www.federalregister.gov/documents/2026/03/30/2026-06052/bulk-manufacturer-of-controlled-substances-application-chemtos-llc Sub: Justice Department, Drug Enforcement Administration Content: Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 4. Importer of Controlled Substances Application: Usona Institute Link: https://www.federalregister.gov/documents/2026/03/30/2026-06051/importer-of-controlled-substances-application-usona-institute Sub: Justice Department, Drug Enforcement Administration Content: Usona Institute. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-03-23
Justice Department, Drug Enforcement Administration Briefing 2026-03-23 Estimated reading time: 5 minutes 1. Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I Link: https://www.federalregister.gov/documents/2026/03/23/2026-05618/schedules-of-controlled-substances-placement-of-3-methoxyphencyclidine Sub: Justice Department, Drug Enforcement Administration Content: With the issuance of this final rule, the Drug Enforcement Administration places substance 3-methoxyphencyclidine (1-(1-(3- methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 3-MeO-PCP. 2. Notice of Lodging of Proposed Modification to Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act Link: https://www.federalregister.gov/documents/2026/03/23/2026-05593/notice-of-lodging-of-proposed-modification-to-consent-decree-under-the-comprehensive-environmental Sub: Justice Department Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-03-20
Justice Department, Drug Enforcement Administration Briefing 2026-03-20 Estimated reading time: 5 minutes 1. Exempt Chemical Preparations Under the Controlled Substances Act Link: https://www.federalregister.gov/documents/2026/03/20/2026-05486/exempt-chemical-preparations-under-the-controlled-substances-act Sub: Justice Department, Drug Enforcement Administration Content: The applications for exempt chemical preparations received by the Drug Enforcement Administration between September 1, 2024, and December 31, 2025, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through December 31, 2025, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published. 2. Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments Link: https://www.federalregister.gov/documents/2026/03/20/2026-05482/ordering-schedule-i-and-ii-controlled-substances-using-dea-form-222-technical-amendments Sub: Justice Department, Drug Enforcement Administration Content: On September 30, 2019, the Drug Enforcement Administration (DEA) published the final rule, New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222). The final rule implemented a new single sheet format for DEA Form 222 and provided for a two-year transition period to switch from the triplicate form. This technical amendment corrects certain regulations erroneously not amended in the final rule which creates ambiguities. The amendment clarifies that a DEA Form 222 Power of Attorney may only be executed or revoked by a registrant, a partner of the registrant, or an officer of a registrant corporate entity. It resolves ambiguity over who may sign a DEA Form 222 and removes the obsolete transition provision for the triplicate version of DEA Form 222. These are conforming revisions that do not make any substantive changes to the regulations. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Importer of Controlled Substances Application: Pisgah Laboratories Inc
Pisgah Laboratories Inc Applies to Import Controlled Substances Estimated reading time: 1–3 minutes Pisgah Laboratories Inc Applies to Import Controlled Substances The Drug Enforcement Administration (DEA) has received an application from Pisgah Laboratories Inc. The company wishes to be registered as an importer of certain controlled substances. Pisgah Laboratories Inc is based at 3222 Old Hendersonville Highway, Pisgah Forest, North Carolina. They applied for registration on January 23, 2026. The controlled substances they wish to import are Phenylacetone, Ecgonine, Thebaine, and Tapentadol. These substances are classified under Schedule II. This means they have some accepted medical uses but also a high potential for abuse. The DEA is accepting comments from the public. People can send their comments electronically until April 20, 2026. Comments can be submitted at the Federal eRulemaking Portal found at www.regulations.gov. If anyone wishes to object to this registration, they can also file a request for a hearing. This request must be sent to the DEA by April 20, 2026. All requests should be addressed to the DEA’s Hearing Clerk and Administrator at the address provided. The DEA will approve Pisgah Laboratories Inc’s application only if their business activities align with the law. The company plans to produce these substances in bulk to distribute them to their customers. However, they cannot import finished drug products that are approved or not approved by the Food and Drug Administration for commercial sale. Thomas Prevoznik, the Deputy Assistant Administrator, signed the notice. The DEA continues to regulate controlled substances to ensure public safety and compliance with the law. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-03-19
Justice Department Briefing 2026-03-19 Estimated reading time: 5 minutes 1. Agency Information Collection Activities; Extension of Previously Approved eCollection eComments Requested; Certification of Compliance With the Statutory Eligibility Requirements of the Violence Against Women Act as Amended, STOP Formula Grant Program Link: https://www.federalregister.gov/documents/2026/03/19/2026-05397/agency-information-collection-activities-extension-of-previously-approved-ecollection-ecomments Sub: Justice Department Content: The Department of Justice (DOJ), Office on Violence Against Women, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Agency Information Collection Activities; Extension of Previously Approved eCollection eComments Requested; Title-Semi-Annual Progress Report for Justice for Families Program Link: https://www.federalregister.gov/documents/2026/03/19/2026-05396/agency-information-collection-activities-extension-of-previously-approved-ecollection-ecomments Sub: Justice Department Content: The Department of Justice (DOJ), Office on Violence Against Women, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Importer of Controlled Substances Application: Pisgah Laboratories Inc Link: https://www.federalregister.gov/documents/2026/03/19/2026-05360/importer-of-controlled-substances-application-pisgah-laboratories-inc Sub: Justice Department, Drug Enforcement Administration Content: Pisgah Laboratories Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 4. Importer of Controlled Substances Application: United States Pharmacopeial Convention Link: https://www.federalregister.gov/documents/2026/03/19/2026-05359/importer-of-controlled-substances-application-united-states-pharmacopeial-convention Sub: Justice Department, Drug Enforcement Administration Content: United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 5. Bulk Manufacturer of Controlled Substances Application: Siegfried Grafton, Inc. Link: https://www.federalregister.gov/documents/2026/03/19/2026-05358/bulk-manufacturer-of-controlled-substances-application-siegfried-grafton-inc Sub: Justice Department, Drug Enforcement Administration Content: Siegfried Grafton, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 6. Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC Link: https://www.federalregister.gov/documents/2026/03/19/2026-05357/bulk-manufacturer-of-controlled-substances-application-sterling-wisconsin-llc Sub: Justice Department, Drug Enforcement Administration Content: Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 7. Importer of Controlled Substances Application: Siegfried Grafton, Inc. Link: https://www.federalregister.gov/documents/2026/03/19/2026-05356/importer-of-controlled-substances-application-siegfried-grafton-inc Sub: Justice Department, Drug Enforcement Administration Content: Siegfried Grafton, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 8. Importer of Controlled Substances Application: Patheon API Services, Inc. Link: https://www.federalregister.gov/documents/2026/03/19/2026-05355/importer-of-controlled-substances-application-patheon-api-services-inc Sub: Justice Department, Drug Enforcement Administration Content: Patheon API Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 9. Importer of Controlled Substances Application: SpecGx LLC Link: https://www.federalregister.gov/documents/2026/03/19/2026-05353/importer-of-controlled-substances-application-specgx-llc Sub: Justice Department, Drug Enforcement Administration Content: SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-03-16
Justice Department, Briefing 2026-03-16 Estimated reading time: 5 minutes 1. Certification Process for State Capital Counsel Systems Link: https://www.federalregister.gov/documents/2026/03/16/2026-05134/certification-process-for-state-capital-counsel-systems Sub: Justice Department, Content: Chapter 154 of title 28, United States Code, provides special procedures for federal habeas corpus review of cases brought by prisoners in state custody who are under a sentence of death. The special procedures are available to States that the Attorney General has certified as having established mechanisms for the appointment, compensation, and payment of reasonable litigation expenses of competent counsel in state postconviction proceedings brought by indigent prisoners, and as providing standards of competency for the appointment of counsel in these proceedings. This rule would remove impediments to certification that chapter 154 does not authorize and would enable more prompt decisions on States' requests for certification. 2. Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I Link: https://www.federalregister.gov/documents/2026/03/16/2026-05064/schedules-of-controlled-substances-temporary-placement-of-bromazolam-in-schedule-i Sub: Justice Department, Drug Enforcement Administration Content: The Drug Enforcement Administration issues this temporary order to schedule 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing bromazolam in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-03-05
Justice Department, Briefing 2026-03-05 Estimated reading time: 5 minutes 1. Review of State Bar Complaints and Allegations Against Department of Justice Attorneys Link: https://www.federalregister.gov/documents/2026/03/05/2026-04390/review-of-state-bar-complaints-and-allegations-against-department-of-justice-attorneys Sub: Justice Department Content: The Department of Justice (“Department”) proposes to establish a process for reviewing bar complaints and allegations against its attorneys. Under the proposed rule, before a current or former Department lawyer may participate in any investigative steps initiated by the bar disciplinary authority of a State, Territory, or the District of Columbia in response to allegations that a current or former Department attorney violated an ethics rule while engaging in that attorney’s federal duties, the Department will have the right to review the allegations in the first instance and shall request that the bar disciplinary authority suspend any parallel investigations until the completion of the Department’s review. 2. Agency Information Collection Activities; Proposed Collection eComments Requested; Revision of a Previously Approved Collection; Title-Request To Be Included on the List of Pro Bono Legal Service Providers for Individuals in Immigration Proceedings (Form EOIR-56) Link: https://www.federalregister.gov/documents/2026/03/05/2026-04332/agency-information-collection-activities-proposed-collection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Executive Office for Immigration Review (EOIR) at the Department of Justice (DOJ) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Agency Information Collection Activities; Proposed Collection eComments Requested; Extension of a Previously Approved Collection; Title-Change of Address/Contact Information Form Link: https://www.federalregister.gov/documents/2026/03/05/2026-04330/agency-information-collection-activities-proposed-collection-ecomments-requested-extension-of-a Sub: Justice Department Content: In accordance with the Paperwork Reduction of 1995 (PRA), the Executive Office for Immigration Review (EOIR), Department of Justice (DOJ), requested the Office of Management and Budget (OMB) conduct an emergency review and approval of a revision to a currently approved collection of information. EOIR requested and OMB granted emergency approval on March 2, 2026, authorizing the revised collection through July 31, 2026. EOIR is providing the public with an opportunity to comment on the proposed collection. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-03-05
Justice Department, Briefing 2026-03-05 Estimated reading time: 5 minutes 1. Review of State Bar Complaints and Allegations Against Department of Justice Attorneys Link: https://www.federalregister.gov/documents/2026/03/05/2026-04390/review-of-state-bar-complaints-and-allegations-against-department-of-justice-attorneys Sub: Justice Department Content: The Department of Justice ("Department") proposes to establish a process for reviewing bar complaints and allegations against its attorneys. Under the proposed rule, before a current or former Department lawyer may participate in any investigative steps initiated by the bar disciplinary authority of a State, Territory, or the District of Columbia in response to allegations that a current or former Department attorney violated an ethics rule while engaging in that attorney's federal duties, the Department will have the right to review the allegations in the first instance and shall request that the bar disciplinary authority suspend any parallel investigations until the completion of the Department's review. 2. Agency Information Collection Activities; Proposed Collection eComments Requested; Revision of a Previously Approved Collection; Title-Request To Be Included on the List of Pro Bono Legal Service Providers for Individuals in Immigration Proceedings (Form EOIR-56) Link: https://www.federalregister.gov/documents/2026/03/05/2026-04332/agency-information-collection-activities-proposed-collection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Executive Office for Immigration Review (EOIR) at the Department of Justice (DOJ) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Agency Information Collection Activities; Proposed Collection eComments Requested; Extension of a Previously Approved Collection; Title-Change of Address/Contact Information Form Link: https://www.federalregister.gov/documents/2026/03/05/2026-04330/agency-information-collection-activities-proposed-collection-ecomments-requested-extension-of-a Sub: Justice Department Content: In accordance with the Paperwork Reduction of 1995 (PRA), the Executive Office for Immigration Review (EOIR), Department of Justice (DOJ), requested the Office of Management and Budget (OMB) conduct an emergency review and approval of a revision to a currently approved collection of information. EOIR requested and OMB granted emergency approval on March 2, 2026, authorizing the revised collection through July 31, 2026. EOIR is providing the public with an opportunity to comment on the proposed collection. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-03-04
Justice Department, Drug Enforcement Administration Briefing 2026-03-04 Estimated reading time: 5 minutes 1. Importer of Controlled Substances Application: Parexel International, LLC Link: https://www.federalregister.gov/documents/2026/03/04/2026-04308/importer-of-controlled-substances-application-parexel-international-llc Sub: Justice Department, Drug Enforcement Administration Content: Parexel International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 2. Importer of Controlled Substances Application: Maridose LLC Link: https://www.federalregister.gov/documents/2026/03/04/2026-04307/importer-of-controlled-substances-application-maridose-llc Sub: Justice Department, Drug Enforcement Administration Content: Maridose LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 3. Bulk Manufacturer of Controlled Substances Application: Restek Corporation Link: https://www.federalregister.gov/documents/2026/03/04/2026-04306/bulk-manufacturer-of-controlled-substances-application-restek-corporation Sub: Justice Department, Drug Enforcement Administration Content: Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 4. Importer of Controlled Substances Application: Patheon API Inc. Link: https://www.federalregister.gov/documents/2026/03/04/2026-04305/importer-of-controlled-substances-application-patheon-api-inc Sub: Justice Department, Drug Enforcement Administration Content: Patheon API Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 5. Importer of Controlled Substances Application: Stepan Company Link: https://www.federalregister.gov/documents/2026/03/04/2026-04303/importer-of-controlled-substances-application-stepan-company Sub: Justice Department, Drug Enforcement Administration Content: Stepan Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 6. Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection; Corporate Whistleblower Awards Pilot Program Online Intake Portal Link: https://www.federalregister.gov/documents/2026/03/04/2026-04300/agency-information-collection-activities-proposed-ecollection-ecomments-requested-new-collection Sub: Justice Department Content: The Criminal Division, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 7. Importer of Controlled Substances Application: Restek Corporation Link: https://www.federalregister.gov/documents/2026/03/04/2026-04299/importer-of-controlled-substances-application-restek-corporation Sub: Justice Department, Drug Enforcement Administration Content: Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 8. Importer of Controlled Substances Application: Catalent Greenville, Inc. Link: https://www.federalregister.gov/documents/2026/03/04/2026-04296/importer-of-controlled-substances-application-catalent-greenville-inc Sub: Justice Department, Drug Enforcement Administration Content: Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 9. Importer of Controlled Substances Application: Amneal Pharmaceuticals, LLC Link: https://www.federalregister.gov/documents/2026/03/04/2026-04289/importer-of-controlled-substances-application-amneal-pharmaceuticals-llc Sub: Justice Department, Drug Enforcement Administration Content: Amneal Pharmaceuticals, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-03-02
Justice Department Regulatory Updates – March 2, 2026 Estimated reading time: 5 minutes 1. Office of the Chief Administrative Hearing Officer Electronic Filing Link: https://www.federalregister.gov/documents/2026/03/02/2026-04136/office-of-the-chief-administrative-hearing-officer-electronic-filing Sub: Justice Department, Executive Office for Immigration Review Content: The Executive Office for Immigration Review ("EOIR") is implementing electronic filing and records applications for all cases before the Office of the Chief Administrative Hearing Officer ("OCAHO"). This interim final rule ("IFR") updates the relevant regulations necessary to implement these electronic filing and records applications, including by requiring certain users to file documents electronically and changing service of process methods. This IFR also includes several additional minor changes to OCAHO's rules of practice and procedure to clarify and improve upon the existing regulatory language. 2. Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act Link: https://www.federalregister.gov/documents/2026/03/02/2026-04112/schedules-of-controlled-substances-placement-of-clonazolam-diclazepam-etizolam-flualprazolam-and Sub: Justice Department, Drug Enforcement Administration Content: With the issuance of this final rule, the Drug Enforcement Administration places clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam and their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. These five substances were temporarily scheduled in an order dated July 26, 2023, and subsequently extended until July 26, 2026, pursuant to an extension published elsewhere in this issue of the Federal Register. This action also enables the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action makes permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle these five specific controlled substances. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-02-23
Justice Department Briefing 2026-02-23 Estimated reading time: 5 minutes 1. Agency Information Collection Activities; Proposed eCollection; eComments Requested; Revision of a Previously Approved Collection; Title: Immigrant and Employee Rights Section Charge Form Link: https://www.federalregister.gov/documents/2026/02/23/2026-03580/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Civil Rights Division, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Information Warfare Research Project Consortium Link: https://www.federalregister.gov/documents/2026/02/23/2026-03572/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-information-warfare Sub: Justice Department, Antitrust Division 3. Notice Pursuant to the National Cooperative Research and Production Act of 1993-UHD Alliance, INC. Link: https://www.federalregister.gov/documents/2026/02/23/2026-03552/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-uhd-alliance-inc Sub: Justice Department, Antitrust Division 4. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Canton Foundation (F/K/A Global Synchronizer Foundation) Link: https://www.federalregister.gov/documents/2026/02/23/2026-03551/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-canton-foundation Sub: Justice Department, Antitrust Division 5. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Defense Industrial Based Consortium Link: https://www.federalregister.gov/documents/2026/02/23/2026-03546/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-defense-industrial Sub: Justice Department, Antitrust Division 6. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Undersea Technology Innovation Consortium Link: https://www.federalregister.gov/documents/2026/02/23/2026-03544/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-undersea-technology Sub: Justice Department, Antitrust Division 7. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Naval Surface Technology & Innovation Consortium Link: https://www.federalregister.gov/documents/2026/02/23/2026-03539/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-naval-surface Sub: Justice Department, Antitrust Division 8. Notice Pursuant to the National Cooperative Research and Production Act of 1993-The Customer Experience Hub Link: https://www.federalregister.gov/documents/2026/02/23/2026-03537/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-the-customer Sub: Justice Department, Antitrust Division 9. Notice Pursuant to the National Cooperative Research and Production Act of 1993-National Armaments Consortium Link: https://www.federalregister.gov/documents/2026/02/23/2026-03536/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-national-armaments Sub: Justice Department, Antitrust Division 10. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Resilient Infrastructure + Secure Energy Consortium Link: https://www.federalregister.gov/documents/2026/02/23/2026-03535/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-resilient Sub: Justice Department, Antitrust Division 11. Notice Pursuant to the National Cooperative Research and Production Act of 1993-America’s Datahub Consortium Link: https://www.federalregister.gov/documents/2026/02/23/2026-03534/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-americas-datahub Sub: Justice Department, Antitrust Division 12. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Training & Readiness Accelerator II Link: https://www.federalregister.gov/documents/2026/02/23/2026-03533/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-training-and Sub: Justice Department, Antitrust Division 13. Granting of Relief; Federal Firearms Privileges Link: https://www.federalregister.gov/documents/2026/02/23/2026-03458/granting-of-relief-federal-firearms-privileges Sub: Justice Department Content: The Attorney General has granted relief from disabilities imposed by Federal laws with respect to certain individuals regarding the acquisition, receipt, transfer, shipment, transportation, or possession of firearms or ammunition. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-02-20
Justice Department Briefing 2026-02-20 Estimated reading time: 5 minutes 1. Agency Information Collection Activities; Proposed eCollection eComments Requested; Title-Explosives Licensee/Permittee Out-of-Business Records Link: https://www.federalregister.gov/documents/2026/02/20/2026-03395/agency-information-collection-activities-proposed-ecollection-ecomments-requested-title-explosives Sub: Justice Department Content: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Title-Identifying/Marking Explosive Materials Link: https://www.federalregister.gov/documents/2026/02/20/2026-03394/agency-information-collection-activities-proposed-ecollection-ecomments-requested Sub: Justice Department Content: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Agency Information Collection Activities; Proposed eCollection eComments Requested; Application/Permit To Import Firearms, Ammunition, and Defense Articles-ATF Form 5330.3A (Form 6, Part I) Link: https://www.federalregister.gov/documents/2026/02/20/2026-03393/agency-information-collection-activities-proposed-ecollection-ecomments-requested-applicationpermit Sub: Justice Department Content: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 4. Agency Information Collection Activities; Proposed eCollection eComments Requested; Title-National Response Team Customer Satisfaction Survey Link: https://www.federalregister.gov/documents/2026/02/20/2026-03391/agency-information-collection-activities-proposed-ecollection-ecomments-requested-title-national Sub: Justice Department Content: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-02-13
Justice Department, Drug Enforcement Administration Briefing 2026-02-13 Estimated reading time: 5 minutes 1. Importer of Controlled Substances Application: S&B Pharma LLC DBA Norac Pharma Link: https://www.federalregister.gov/documents/2026/02/13/2026-02914/importer-of-controlled-substances-application-sandb-pharma-llc-dba-norac-pharma Sub: Justice Department, Drug Enforcement Administration Content: S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 2. Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics, Inc. Link: https://www.federalregister.gov/documents/2026/02/13/2026-02911/bulk-manufacturer-of-controlled-substances-application-siemens-healthcare-diagnostics-inc Sub: Justice Department, Drug Enforcement Administration Content: Siemens Healthcare Diagnostics, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 3. Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute Link: https://www.federalregister.gov/documents/2026/02/13/2026-02909/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-institute Sub: Justice Department, Drug Enforcement Administration Content: Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 4. Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute Link: https://www.federalregister.gov/documents/2026/02/13/2026-02908/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-institute Sub: Justice Department, Drug Enforcement Administration Content: Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 5. John Bender, M.D.; Decision and Order Link: https://www.federalregister.gov/documents/2026/02/13/2026-02902/john-bender-md-decision-and-order Sub: Justice Department, Drug Enforcement Administration 6. Privacy Act of 1974; Implementation Link: https://www.federalregister.gov/documents/2026/02/13/2026-02882/privacy-act-of-1974-implementation Sub: Justice Department Content: The Executive Office for Immigration Review (EOIR), a component within the United States Department of Justice (DOJ or Department), is finalizing without changes its Privacy Act exemption regulations for the system of records titled, Adjudication and Appeal Records of the Office of the Chief Immigration Judge and Board of Immigration Appeals, JUSTICE/EOIR-001, which were published as a Notice of Proposed Rulemaking (NPRM) on August 29, 2025. Specifically, the Department's regulations will exempt the records maintained in JUSTICE/ EOIR-001 from one or more provisions of the Privacy Act. The exemptions are necessary to protect properly classified information and law enforcement sensitive materials maintained in the system. The Department received one anonymous comment in support of this rulemaking in response to the NPRM. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Executive Office for Immigration Review Briefing 2026-02-06
Justice Department Briefing 2026-02-06 Estimated reading time: 5 minutes 1. Notice of Lodging of Proposed Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act Link: https://www.federalregister.gov/documents/2026/02/06/2026-02353/notice-of-lodging-of-proposed-consent-decree-under-the-comprehensive-environmental-response Sub: Justice Department 2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of Currently Approved Collection: Title-Campus Program Grantee Needs and Progress Assessment Tool Link: https://www.federalregister.gov/documents/2026/02/06/2026-02336/agency-information-collection-activities-proposed-ecollection-ecomments-requested-extension-of Sub: Justice Department Content: The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Agency Information Collection Activities; Proposed eCollection eComments Requested Extension of a Currently Approved Collection Title: Data Security Requirements for Accessing Confidential Data Link: https://www.federalregister.gov/documents/2026/02/06/2026-02334/agency-information-collection-activities-proposed-ecollection-ecomments-requested-extension-of-a Sub: Justice Department Content: The Department of Justice, Office of Justice Programs, Bureau of Justice Statistics is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 4. Appellate Procedures for the Board of Immigration Appeals Link: https://www.federalregister.gov/documents/2026/02/06/2026-02326/appellate-procedures-for-the-board-of-immigration-appeals Sub: Justice Department, Executive Office for Immigration Review Content: This interim final rule (“IFR”) amends Department of Justice (“Department” or “DOJ”) regulations to streamline administrative appellate review by the Board of Immigration Appeals (“Board” or “BIA”) of decisions by Immigration Judges by making review of such decisions on the merits discretionary, by setting appropriate times for briefing in cases that are reviewed on the merits, and by streamlining other aspects of the appellate process to ensure timely adjudications and avoid adding to the already sizeable backlog at the Board. Additionally, the Department is making various technical and non- substantive changes to its regulations. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-02-04
Justice Department, Drug Enforcement Administration Briefing 2026-02-04 Estimated reading time: 5 minutes 1. Bulk Manufacturer of Controlled Substances Application: S & B Pharma LLC DBA Norac Pharma Link: https://www.federalregister.gov/documents/2026/02/04/2026-02232/bulk-manufacturer-of-controlled-substances-application-s-and-b-pharma-llc-dba-norac-pharma Sub: Justice Department, Drug Enforcement Administration Content: S & B Pharma LLC DBA Norac Pharma has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 2. Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC Link: https://www.federalregister.gov/documents/2026/02/04/2026-02230/bulk-manufacturer-of-controlled-substances-application-sterling-pharma-usa-llc Sub: Justice Department, Drug Enforcement Administration Content: Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-02-02
Justice Department, Drug Enforcement Administration Briefing 2026-02-02 Estimated reading time: 5 minutes 1. Importer of Controlled Substances Application: Mylan Inc. Link: https://www.federalregister.gov/documents/2026/02/02/2026-01947/importer-of-controlled-substances-application-mylan-inc Sub: Justice Department, Drug Enforcement Administration Content: Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 2. Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare Link: https://www.federalregister.gov/documents/2026/02/02/2026-01946/importer-of-controlled-substances-application-medi-physics-inc-dba-ge-healthcare Sub: Justice Department, Drug Enforcement Administration Content: Medi-Physics Inc. DBA GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 3. Importer of Controlled Substances Application: Sharp Clinical Services, LLC Link: https://www.federalregister.gov/documents/2026/02/02/2026-01944/importer-of-controlled-substances-application-sharp-clinical-services-llc Sub: Justice Department, Drug Enforcement Administration Content: Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 4. Bulk Manufacturer of Controlled Substances Application: Promega Corporation Link: https://www.federalregister.gov/documents/2026/02/02/2026-01940/bulk-manufacturer-of-controlled-substances-application-promega-corporation Sub: Justice Department, Drug Enforcement Administration Content: Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Antitrust Division Briefing 2026-01-27
Justice Department Federal Register Briefing – January 27, 2026 Estimated reading time: 5 minutes 1. Adam Maass, M.D.; Decision and Order Link: https://www.federalregister.gov/documents/2026/01/27/2026-01499/adam-maass-md-decision-and-order Sub: Justice Department, Drug Enforcement Administration 2. Complete Care Pharmacy, LLC; Decision and Order Link: https://www.federalregister.gov/documents/2026/01/27/2026-01498/complete-care-pharmacy-llc-decision-and-order Sub: Justice Department, Drug Enforcement Administration 3. Allied Medical Products, Inc.; Decision and Order Link: https://www.federalregister.gov/documents/2026/01/27/2026-01496/allied-medical-products-inc-decision-and-order Sub: Justice Department, Drug Enforcement Administration 4. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Cable Television Laboratories, Inc. Link: https://www.federalregister.gov/documents/2026/01/27/2026-01478/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-cable-television Sub: Justice Department, Antitrust Division Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department Briefing 2026-01-23
Justice Department Briefing 2026-01-23 Estimated reading time: 5 minutes 1. Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Title: National Standards To Prevent, Detect, and Respond to Prison Rape (28 CFR Part 115) Link: https://www.federalregister.gov/documents/2026/01/23/2026-01323/agency-information-collection-activities-proposed-ecollection-ecomments-requested-extension-of-a Sub: Justice Department Content: The Office of Justice Programs, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Claims Public Safety Officer Medal of Valor Application Link: https://www.federalregister.gov/documents/2026/01/23/2026-01322/agency-information-collection-activities-proposed-ecollection-ecomments-requested-extension-of-a Sub: Justice Department Content: The Office of Justice Programs, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 3. Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry Link: https://www.federalregister.gov/documents/2026/01/23/2026-01305/bulk-manufacturer-of-controlled-substances-application-organic-consultants-llc-dba-cascade-chemistry Sub: Justice Department, Drug Enforcement Administration Content: Organic Consultants, LLC DBA Cascade Chemistry has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 4. Bulk Manufacturer of Controlled Substances Application: Maridose LLC Link: https://www.federalregister.gov/documents/2026/01/23/2026-01298/bulk-manufacturer-of-controlled-substances-application-maridose-llc Sub: Justice Department, Drug Enforcement Administration Content: Maridose LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 5. Agency Information Collection Activities; Extension of Previously Approved eCollection eComments Requested; Semi-Annual Performance Reporting Form for Financial Assistance Grants for Victims of Sexual Assault, Domestic Violence, Dating Violence, and Stalking Program (FAV Program) Link: https://www.federalregister.gov/documents/2026/01/23/2026-01266/agency-information-collection-activities-extension-of-previously-approved-ecollection-ecomments Sub: Justice Department Content: The Department of Justice (DOJ), Office on Violence Against Women, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 6. Agency Information Collection Activities; Extension of Previously Approved eCollection eComments Requested; Semi-Annual Performance Reporting Form for the Demonstration Program on Trauma-Informed, Victim-Centered Training for Law Enforcement on Domestic Violence, Dating Violence, Sexual Assault, and Stalking (Abby Honold Program) Link: https://www.federalregister.gov/documents/2026/01/23/2026-01264/agency-information-collection-activities-extension-of-previously-approved-ecollection-ecomments Sub: Justice Department Content: The Department of Justice (DOJ), Office on Violence Against Women, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 7. Agency Information Collection Activities; Extension of Previously Approved eCollection eComments Requested; Title-Semi-Annual Performance Reporting Form for the Local Law Enforcement Grants for Enforcement of Cybercrimes Program (Cybercrimes Enforcement Program) Link: https://www.federalregister.gov/documents/2026/01/23/2026-01263/agency-information-collection-activities-extension-of-previously-approved-ecollection-ecomments Sub: Justice Department Content: The Department of Justice (DOJ), Office on Violence Against Women, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 8. Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Title-United States Victim of State Sponsored Terrorism Fund Application Link: https://www.federalregister.gov/documents/2026/01/23/2026-01260/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a Sub: Justice Department Content: The Criminal Division, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 9. Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection; Title-Return A-Monthly Return of Offenses Known to Police and Supplement to Return A-Monthly Return of Offenses Known to Police Link: https://www.federalregister.gov/documents/2026/01/23/2026-01257/agency-information-collection-activities-proposed-ecollection-ecomments-requested-extension-of-a Sub: Justice Department Content: The Criminal Justice Information Services (CJIS) Division, FBI, DOJ, will be submitting the following information collection request to OMB for review and approval in accordance with the Paperwork Reduction Act (PRA) of 1995. 10. Agency Information Collection Activities; Proposed eCollection eComments Requested; Title-Revision of Currently Approved Collection Survey: Annual Survey of Jails in Indian Country Link: https://www.federalregister.gov/documents/2026/01/23/2026-01253/agency-information-collection-activities-proposed-ecollection-ecomments-requested-title-revision-of Sub: Justice Department Content: The Bureau of Justice Statistics (BJS), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Alcohol, Tobacco, Firearms, and Explosives Bureau Briefing 2026-01-22
Justice Department Briefing 2026-01-22 Estimated reading time: 5 minutes 1. Importer of Controlled Substances Application: Siegfried USA, LLC Link: https://www.federalregister.gov/documents/2026/01/22/2026-01194/importer-of-controlled-substances-application-siegfried-usa-llc Sub: Justice Department, Drug Enforcement Administration Content: Siegfried USA, LLC has applied to be registered as an importer of basic class(es) of controlled substances(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. 2. Revising Definition of “Unlawful User of or Addicted to Controlled Substance” Link: https://www.federalregister.gov/documents/2026/01/22/2026-01141/revising-definition-of-unlawful-user-of-or-addicted-to-controlled-substance Sub: Justice Department, Alcohol, Tobacco, Firearms, and Explosives Bureau Content: The Bureau of Alcohol, Tobacco, Firearms, and Explosives (“ATF”) is amending Department of Justice (“Department”) regulations to update the definition of “unlawful user of or addicted to any controlled substance,” a category of persons who may not possess firearms under federal law. This definition was established in 1996 to facilitate operation of the National Instant Criminal Background Check System. Since then, court decisions and ATF internal guidance have evolved to include recurring use as a factor. As a result, ATF is aligning the definition with the best statutory understanding, as informed by judicial decisions. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Antitrust Division Briefing 2026-01-21
Justice Department Briefing 2026-01-21 Estimated reading time: 5 minutes 1. Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc. Link: https://www.federalregister.gov/documents/2026/01/21/2026-01072/importer-of-controlled-substances-application-mylan-pharmaceuticals-inc Sub: Justice Department, Drug Enforcement Administration Content: Mylan Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 2. Inflation Adjustment for EOIR OBBBA Fees; Fiscal Year 2026 Link: https://www.federalregister.gov/documents/2026/01/21/2026-01012/inflation-adjustment-for-eoir-obbba-fees-fiscal-year-2026 Sub: Justice Department, Executive Office for Immigration Review Content: The Department of Justice (“Department”) is announcing inflationary adjustments to immigration-related fees for filings with the Executive Office for Immigration Review (“EOIR”) under the One Big Beautiful Bill Act (“OBBBA”) for Fiscal Year (“FY”) 2026. OBBBA requires the Attorney General to annually adjust for inflation the OBBBA fees that EOIR collects. This notice sets out the EOIR-collected OBBBA fees for the remainder of FY 2026 and their effective dates. 3. United States of America et al. v. RealPage, Inc. et al. Proposed Final Judgment and Competitive Impact Statement Link: https://www.federalregister.gov/documents/2026/01/21/2026-01009/united-states-of-america-et-al-v-realpage-inc-et-al-proposed-final-judgment-and-competitive-impact Sub: Justice Department, Antitrust Division Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-01-19
Justice Department Briefing — January 20, 2026 Estimated reading time: 5 minutes 1. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium Link: https://www.federalregister.gov/documents/2026/01/20/2026-00967/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-medical-cbrn-defense Sub: Justice Department, Antitrust Division 2. Notice Pursuant to the National Cooperative Research and Production Act of 1993-OpenJS Foundation Link: https://www.federalregister.gov/documents/2026/01/20/2026-00963/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-openjs-foundation Sub: Justice Department, Antitrust Division 3. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Cooperative Research Group on Separation Technology (STAR) Program: Phase 3 (Star Phase 3) Link: https://www.federalregister.gov/documents/2026/01/20/2026-00962/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-cooperative-research Sub: Justice Department, Antitrust Division 4. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Mercury Consortium, Inc. Link: https://www.federalregister.gov/documents/2026/01/20/2026-00961/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-mercury-consortium Sub: Justice Department, Antitrust Division 5. Notice Pursuant to the National Cooperative Research and Production Act of 1993-PXI Systems Alliance, Inc. Link: https://www.federalregister.gov/documents/2026/01/20/2026-00956/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-pxi-systems-alliance Sub: Justice Department, Antitrust Division 6. Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I Link: https://www.federalregister.gov/documents/2026/01/20/2026-00954/schedules-of-controlled-substances-temporary-placement-of-2-fluorodeschloroketamine-in-schedule-i Sub: Justice Department, Drug Enforcement Administration Content: The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one (commonly known as 2-fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in Schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule I controlled substances on persons who handle or propose to handle 2-fluorodeschloroketamine. 7. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Biopharmaceutical Manufacturing Preparedness Consortium Link: https://www.federalregister.gov/documents/2026/01/20/2026-00953/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-biopharmaceutical Sub: Justice Department, Antitrust Division 8. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Pistoia Alliance, Inc. Link: https://www.federalregister.gov/documents/2026/01/20/2026-00951/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-pistoia-alliance-inc Sub: Justice Department, Antitrust Division 9. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Mobile Satellite Services Association Link: https://www.federalregister.gov/documents/2026/01/20/2026-00950/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-mobile-satellite Sub: Justice Department, Antitrust Division 10. Definition of “Cannabimimetic Agents” and Assignment of an Administration Controlled Substances Code Number for All “Cannabimimetic Agents” Link: https://www.federalregister.gov/documents/2026/01/20/2026-00907/definition-of-cannabimimetic-agents-and-assignment-of-an-administration-controlled-substances-code Sub: Justice Department, Drug Enforcement Administration Content: The Drug Enforcement Administration is publishing this final rule to amend its regulations related to “cannabimimetic agents” by including the term’s definition, identifying 18 additional substances that meet the definition, and consolidating most existing administration controlled substances code numbers into a single code number for such substances. Two schedule I “cannabimimetic agents,” JWH-018 and AM2201, are moved to the “hallucinogens” paragraph of schedule I but retain their existing codes to facilitate quota and international reporting. The rule does not change their schedule I status; these substances will be assigned a new controlled substances code number once the rule becomes effective. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Justice Department, Drug Enforcement Administration Briefing 2026-01-16
Justice Department Briefing 2026-01-16 Estimated reading time: 5 minutes 1. Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Claim for Damage, Injury, or Death Link: https://www.federalregister.gov/documents/2026/01/16/2026-00851/agency-information-collection-activities-proposed-ecollection-ecomments-requested-extension-of-a Sub: Justice Department Content: The Civil Division, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC Link: https://www.federalregister.gov/documents/2026/01/16/2026-00833/bulk-manufacturer-of-controlled-substances-application-siegfried-usa-llc Sub: Justice Department, Drug Enforcement Administration Content: Siegfried USA, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Federal Notice: AndersonBrecon, Inc. DBA PCI Pharma Services Applies To Import LSD For Clinical Trials Estimated reading time: 3–5 minutes On January 8, 2026, the United States Drug Enforcement Administration (DEA) announced a new application from AndersonBrecon, Inc. DBA PCI Pharma Services. The company, based at 5775 Logistics Parkway, Rockford, Illinois 61109-3608, has requested permission to import a controlled substance. The controlled substance is lysergic acid diethylamide, also known as LSD. The drug code for LSD is 7315. LSD is classified by the government as a Schedule I drug. AndersonBrecon, Inc. wants to import LSD only for use in clinical trials. No other activities with LSD are allowed under this application. The company is not allowed to import FDA-approved or non-approved finished dosage forms for commercial sale. The DEA states that approval for importing will only happen if the company’s activities match what is allowed under United States law, specifically 21 U.S.C. 952(a)(2). Other companies or people who already make or use LSD in bulk can send comments or objections to the proposed registration. They may also request a hearing. All comments or hearing requests must be submitted by February 9, 2026. Comments should be sent through the Federal eRulemaking Portal at https://www.regulations.gov. For hearings, requests must be sent to: Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152 Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152 Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152 The DEA notice was signed by Thomas Prevoznik, Deputy Assistant Administrator. This public notice appears in the Federal Register, Volume 91, Number 5, on January 8, 2026, pages 724-725. The docket number is DEA-1638. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
DEA Notice: Janssen Pharmaceuticals Applies to Import Controlled Substances Estimated reading time: 2–3 minutes Date: January 8, 2026 Who applied: Janssen Pharmaceuticals Inc. applied to be registered as an importer of specific controlled substances. Address: 1440 Olympic Drive, Buildings 1-5 & 7-14, Athens, Georgia 30601-1645. Controlled Substances Requested: Ethylphenidate (Drug code: 1727, Schedule I) Methylphenidate (Drug code: 1724, Schedule II) Purpose: Janssen plans to import these substances only for analytical purposes. No other activities involving these drug codes are permitted under this registration. Regulatory Information: The application follows 21 CFR 1301.34(a). Permit approvals will happen only if the business activity fits U.S. law, specifically 21 U.S.C. 952(a)(2). The permission does not allow the import of finished drugs, whether FDA-approved or not, for sale. Comments and Hearings: Registered bulk manufacturers and applicants can submit electronic comments or objections by February 9, 2026. Requests for a hearing about the application must be submitted by February 9, 2026. Comments must be made at https://www.regulations.gov. Hearing requests must be sent to the DEA at 8701 Morrissette Drive, Springfield, Virginia 22152, to the Attention of the Hearing Clerk/OALJ, DEA Federal Register Representative/DPW, and the Administrator. Notice Published By: Thomas Prevoznik, Deputy Assistant Administrator. Document Number: 2026-00128 Date Filed: January 7, 2026 For more information, visit the official Federal Register website. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Importer of Controlled Substances Application: Curium US LLC
Curium US LLC Applies to Import Controlled Substance Estimated reading time: 2–4 minutes Curium US LLC has applied to become an importer of a controlled substance. This information was released by the Drug Enforcement Administration (DEA) in a notice published on January 8, 2026. The application is for importing a substance called ecgonine. The drug code for ecgonine is 9180. Ecgonine is listed as a Schedule II controlled substance. Curium US LLC is located at 2703 Wagner Place, Maryland Heights, Missouri 63043-3421. The company wants to import small amounts of a derivative form of ecgonine. The purpose is to use the substance for manufacturing. No other activities for this drug code are allowed under this registration. Anyone interested in this proposed registration can send a comment or objection. Comments must be submitted electronically through the Federal eRulemaking Portal at https://www.regulations.gov. The deadline to submit comments or requests for a hearing is February 9, 2026. People who want a hearing need to send their request to the DEA at 8701 Morrissette Drive, Springfield, Virginia 22152. The DEA will approve permit applications only if they fit the rules described in 21 U.S.C. 952(a)(2). The authorization does not allow for importing finished dosage forms, whether they are approved or not by the Food and Drug Administration (FDA), for commercial sale. The notice was signed by Thomas Prevoznik, Deputy Assistant Administrator at the DEA. For more information, see the notice published in the Federal Register Volume 91, Number 5, on January 8, 2026. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Importer of Controlled Substances Application: Mylan Technologies Inc.
Mylan Technologies Applies to Import Controlled Substances for Testing Estimated reading time: 2–3 minutes Mylan Technologies Inc. has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of controlled substances. The application was officially filed on October 7, 2025. Mylan Technologies is located at 110 Lake Street, Saint Albans, Vermont 05478-2266. The company seeks to import two specific controlled substances. These are: Methylphenidate (Drug code 1724, Schedule II) Fentanyl (Drug code 9801, Schedule II) Mylan plans to import these substances in finished dosage form (FDF) from foreign sources. The imports will be used for analytical testing and clinical trials. In these trials, the foreign FDF will be compared to the company’s own FDF made in the United States for foreign markets. The registration does not authorize other activities for these drug codes. The permit is only for testing and trials. It does not allow the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. The DEA will grant approval only if the registrant’s activities match what is allowed under U.S. law. Other uses are not permitted. People who make these substances or want to make them may submit comments or objections. Comments must be sent electronically by February 9, 2026. Written requests for a hearing on the application must also be sent by this date. Comments must be submitted through the Federal eRulemaking Portal at regulations.gov. Written hearing requests must be sent to: 1. Drug Enforcement Administration, Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152 2. Drug Enforcement Administration, DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152 3. Drug Enforcement Administration, Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152 This notice follows 21 CFR 1301.34(a), which governs the importation of controlled substances. The announcement was issued by Thomas Prevoznik, Deputy Assistant Administrator of the DEA. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Meeting of the Religious Liberty Commission
Department of Justice Announces Fifth Religious Liberty Commission Meeting Estimated reading time: 3-5 minutes The United States Department of Justice (DOJ) has announced the fifth meeting of the Religious Liberty Commission. The meeting will take place on February 9, 2026, from 8:30 a.m. to 2:30 p.m. The location will be the World Stage Theatre at the Museum of the Bible in Washington, DC. The meeting will also be recorded and broadcast online at justice.gov/live. The Religious Liberty Commission is a federal advisory committee. It was established by the President through Executive Order 14291. The Commission has a chair, a vice chair, and eleven members appointed by the President. Members include people from the private sector, employers, educational institutions, religious communities, States, and three ex-officio members. The Commission gives advice to the Domestic Policy Council and the White House Faith Office. They focus on religious liberty policies in the United States. The Commission will create a detailed report for the President. This report will cover the foundations of religious liberty in America, the impact of religious liberty on American society, current threats to religious liberty in the country, strategies to protect religious liberty for the future, and programs to teach about and support America’s peaceful religious diversity. At the February 9, 2026 meeting, the Commission will discuss religious liberty issues related to anti-Semitism. They will also talk about religious liberty issues in the private sector. The meeting is open to the public. People who want to attend in person must register. Registration is available on the Religious Liberty Commission website at https://www.justice.gov/religious-liberty-commission. Attendance is limited to the number of seats at the venue. All in-person attendees will need to show identification and go through security screening. Media members must register through the Office of Public Affairs by February 5, 2026, at 5 p.m. They must also bring government-issued photo identification and valid media credentials and go through security checks. Anyone can send written comments to the Commission. Comments can be emailed to the contact address listed or sent by mail to the U.S. Department of Justice, Office of the Associate Attorney General, ATTN: Religious Liberty Commission, 950 Pennsylvania Avenue NW, Room 5706, Washington, DC 20530. The deadline for comments is February 1, 2026. For more information or to request a reasonable accommodation to attend, contact Mary Margaret Bush, Director and Designated Federal Officer for the Religious Liberty Commission, at the Department of Justice. The notice of this meeting is issued under the Federal Advisory Committee Act (5 U.S.C. 1001 et seq.). Dated: January 6, 2026.Mary Margaret BushDesignated Federal Officer, Religious Liberty Commission Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Meeting of the Religious Liberty Commission
Department of Justice Announces Sixth Religious Liberty Commission Meeting Estimated reading time: 4–5 minutes The United States Department of Justice has announced the sixth Federal advisory committee meeting of the Religious Liberty Commission. The meeting will be open to the public. It is scheduled for March 16, 2026, from 8:30 a.m. to 2:30 p.m. The meeting will take place at the World Stage Theatre at the Museum of the Bible in Washington, DC. The meeting will be recorded and broadcast live online at justice.gov/live. To attend the meeting in person, registration is required. Attendance is limited by the venue’s capacity. People can register on the Religious Liberty Commission website at here. All attendees must bring identification and go through security. Media guests must register with the Department of Justice Office of Public Affairs by March 12, 2026, at 5 p.m. Media should have government-issued photo I.D. and valid media credentials. Mary Margaret Bush is the Director of the Religious Liberty Commission and serves as the Designated Federal Officer. She can be reached by email or phone at 202-514-2046. She can also help people who need a reasonable accommodation to attend. The Religious Liberty Commission was set up by the President through Executive Order 14291. It has a chair, a vice chair, and eleven members chosen by the President. Members include people from the private sector, states, educational institutions, religious communities, and three ex-officio members. The Commission gives advice to the Domestic Policy Council and the White House Faith Office on religious liberty policies. It will prepare a report to the President. This report will cover the foundations of religious liberty in America, its impact on society, current threats, ways to protect religious liberty for future generations, and programs to celebrate America’s religious diversity. The agenda for the March 16 meeting will focus on religious liberty issues related to healthcare and humanitarian and social services. People can send in written comments by email or mail. The deadline for comments is March 8, 2026. Comments can be emailed or mailed to the U.S. Department of Justice, Office of the Associate Attorney General, Religious Liberty Commission, 950 Pennsylvania Avenue NW, Room 5706 Washington, DC 20530. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. 1001 et seq.). The notice was signed by Mary Margaret Bush, Designated Federal Officer, Religious Liberty Commission, on January 6, 2026. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
DOJ Briefing 2026-01-08
Justice Department Briefing 2026-01-08 Estimated reading time: 5 minutes 1. Meeting of the Religious Liberty Commission Link: https://www.federalregister.gov/documents/2026/01/08/2026-00195/meeting-of-the-religious-liberty-commission Sub: Justice Department Content: The DOJ is publishing this notice to announce the sixth Federal advisory committee meeting of the Religious Liberty Commission (Commission). 2. Meeting of the Religious Liberty Commission Link: https://www.federalregister.gov/documents/2026/01/08/2026-00187/meeting-of-the-religious-liberty-commission Sub: Justice Department Content: The DOJ is publishing this notice to announce the fifth Federal advisory committee meeting of the Religious Liberty Commission (Commission). 3. Importer of Controlled Substances Application: Mylan Technologies Inc. Link: https://www.federalregister.gov/documents/2026/01/08/2026-00130/importer-of-controlled-substances-application-mylan-technologies-inc Sub: Justice Department, Drug Enforcement Administration Content: Mylan Technologies Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 4. Importer of Controlled Substances Application: Curium US LLC Link: https://www.federalregister.gov/documents/2026/01/08/2026-00129/importer-of-controlled-substances-application-curium-us-llc Sub: Justice Department, Drug Enforcement Administration Content: Curium US LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 5. Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc. Link: https://www.federalregister.gov/documents/2026/01/08/2026-00128/importer-of-controlled-substances-application-janssen-pharmaceuticals-inc Sub: Justice Department, Drug Enforcement Administration Content: Janssen Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 6. Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services Link: https://www.federalregister.gov/documents/2026/01/08/2026-00127/importer-of-controlled-substances-application-andersonbrecon-inc-dba-pci-pharma-services Sub: Justice Department, Drug Enforcement Administration Content: AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Kinetochem LLC Applies to Make Controlled Substances in Bulk Estimated reading time: 2–3 minutes On December 3, 2025, the Drug Enforcement Administration (DEA) announced that Kinetochem LLC has applied to be registered as a bulk manufacturer for several controlled substances. The notice was published in the Federal Register, Volume 90, Number 230. Kinetochem LLC is located at 96 Market Street, Suite 102, Georgetown, Texas, 78626-3618. The company applied on October 15, 2025. The application is for these controlled substances: Marihuana (drug code 7360, Schedule I) Tetrahydrocannabinols (drug code 7370, Schedule I) Psilocybin (drug code 7437, Schedule I) Psilocyn (drug code 7438, Schedule I) Kinetochem LLC plans to make these controlled substances in bulk. They will make them as Active Pharmaceutical Ingredients (APIs) for use by customers. The substances will also be used for research and clinical trials. For marihuana and tetrahydrocannabinols, the company will manufacture only synthetic versions. No other activities are allowed for these drug codes with this registration. Anyone who is a registered bulk manufacturer of the affected substances, or is applying to be one, can submit comments or objections to the DEA by February 2, 2026. They can also ask for a hearing by that date. Comments can be submitted electronically at https://www.regulations.gov. After submitting, the commenter will receive a Comment Tracking Number. Comments will not appear on the website right away. This information was provided by Thomas Prevoznik, the Deputy Assistant Administrator of the DEA. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; COPS Progress Report
Department of Justice Seeks Comments on COPS Progress Report Collection Estimated reading time: 3–5 minutes On December 3, 2025, the Department of Justice (DOJ) published a notice in the Federal Register. The notice is about the COPS Progress Report information collection. COPS stands for Community Oriented Policing Services. The DOJ wants public comments for 60 days, until February 2, 2026. The goal is to get feedback about collecting information from state, local, and tribal governments. The notice asks people to answer these questions: Is the collection needed for the Bureau of Justice Statistics to work well? Is the DOJ’s estimate of how much work it will take correct? Can the information collected be clearer and more useful? How can the work for people responding be made easier, such as using electronic forms? Here is an overview of this information collection: Type of Collection: Extension of a previously approved collection. Form Name: COPS Progress Report. Form Number: OMB #1105-0102. DOJ section: COPS. Who Responds: State, Local, and Tribal Governments. Obligation: Mandatory. Respondents: About 4,800 groups. Time Needed per Respondent: 25 minutes. How Often: Four times per year (semi-annually). Total Annual Hours Needed: 600 hours. Estimated Annual Cost: $12,000, based on $20 per hour. If you want more details or need the forms, contact Cory D. Randolph at the Office of Community Oriented Policing Services, Two Constitution Square, 145 N Street NE, Washington, DC 20530. If more information is needed, contact Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Enterprise Portfolio Management, Two Constitution Square, 145 N Street NE, 4W-218, Washington, DC. The notice was signed by Darwin Arceo on December 1, 2025. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
DOJ Briefing 2025-12-03
Justice Department Briefing 2025-12-03 Estimated reading time: 3 minutes 1. Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; COPS Progress Report Sub: Justice Department Content: The COPS, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. 2. Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC Sub: Justice Department, Drug Enforcement Administration Content: Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC
Blue Rabbit Veterinary LLC Applies to Import Controlled Substances Estimated reading time: 1 minute Blue Rabbit Veterinary LLC has applied to be registered as an importer of controlled substances. The application was filed with the Drug Enforcement Administration (DEA), Department of Justice. The company is located at 1680 East Northrop Boulevard, Unit 1, Chandler, Arizona 85286. Blue Rabbit Veterinary LLC seeks to import two controlled substances: Etorphine HCI (Drug code: 9059), Schedule II Thiafentanil (Drug code: 9729), Schedule II The purpose of the import is to distribute the drugs in final dosage form to zoo and wildlife customers. No other activities with these drug codes are allowed for this registration. The notice came in the Federal Register, Volume 90, Number 228, on December 1, 2025. Registered bulk manufacturers and applicants can send objections or comments by December 31, 2025. All comments must be submitted electronically through https://www.regulations.gov. People who want a hearing must send their request to the DEA at 8701 Morrissette Drive, Springfield, Virginia 22152. The DEA will approve permit applications only when the business activity matches what is authorized under 21 U.S.C. 952(a)(2). Authorization will not allow the import of FDA-approved or non-approved finished dosage forms for commercial sale. The notice was signed by Thomas Prevoznik, Deputy Assistant Administrator for the DEA. For more information, refer to Federal Register notice 2025-21719. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Benuvia Operations, LLC Applies to Manufacture Controlled Substances Estimated reading time: 1–4 minutes The Drug Enforcement Administration (DEA) announced that Benuvia Operations, LLC has applied to be a bulk manufacturer of certain controlled substances. The company is located at 3950 North Mays Street, Round Rock, Texas 78665. Benuvia Operations, LLC applied on October 27, 2025. The application is for the following drugs: Lysergic Acid Diethylamide (Drug code: 7315) – Schedule I Codeine (Drug code: 9050) – Schedule II Hydromorphone (Drug code: 9150) – Schedule II Sufentanil (Drug code: 9740) – Schedule II The company wants to make these drugs in bulk. The purpose is for internal research and for making new dosage forms. No other activities are allowed for these drugs under this registration. If other manufacturers or applicants are affected by this notice, they can comment on the application. They must submit their comments electronically by January 30, 2026. Comments must be sent through the Federal eRulemaking Portal at https://www.regulations.gov. Anyone who wants a hearing on this application must also submit a written request by January 30, 2026. Thomas Prevoznik, the Deputy Assistant Administrator, signed this notice. This notice was published in the Federal Register, Volume 90, Number 228, on Monday, December 1, 2025. The document number is 2025-21720. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc.
Invizyne Technologies Applies to Make Controlled Substances Estimated reading time: 1–4 minutes On December 1, 2025, the Drug Enforcement Administration (DEA) published a notice in the Federal Register about Invizyne Technologies, Inc. The notice says that Invizyne Technologies has applied to be a bulk manufacturer of a controlled substance. Invizyne Technologies is based at 750 Royal Oaks Drive, Suite 106, Monrovia, California, 91016-6357. The company wants to make large amounts of a substance called Tetrahydrocannabinols. The drug code for Tetrahydrocannabinols is 7370. It belongs to Schedule I of controlled substances. The company wants to make this substance as a synthetic version. They plan to use it either for making other materials inside their company or to sell it to their customers. This is the only activity allowed for this drug code under this registration. People who are already registered to make bulk amounts of this kind of drug, and people who want to register, can send comments or objections to the DEA. They must do this by January 30, 2026. Anyone who wants to have a hearing about this application has to ask for it by January 30, 2026. All comments need to be sent in electronically through the Federal eRulemaking Portal at https://www.regulations.gov. After sending a comment, people will get a Comment Tracking Number. The comment might not show up on the website right away. The notice was signed by Thomas Prevoznik, Deputy Assistant Administrator at the DEA. This notice is part of the government’s process to let the public know and ask for input when a company applies to make a controlled substance in bulk. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
DOJ Briefing 2025-12-01
Justice Department, Drug Enforcement Administration Briefing 2025-12-01 Estimated reading time: 4 minutes 1. Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc. Sub: Justice Department, Drug Enforcement Administration Content: Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 2. Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC Sub: Justice Department, Drug Enforcement Administration Content: Benuvia Operations, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 3. Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC Sub: Justice Department, Drug Enforcement Administration Content: Blue Rabbit Veterinary LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. 4. Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection Application/Permit To Import Firearms, Ammunition, and Defense Articles-ATF Form 5330.3A (Form 6, Part I) Sub: Justice Department Content: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF), will be submitting the following information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. Legal Disclaimer This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
